234 related articles for article (PubMed ID: 32302553)
41. Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.
Kasperzyk JL; d'Azzo A; Platt FM; Alroy J; Seyfried TN
J Lipid Res; 2005 Apr; 46(4):744-51. PubMed ID: 15687347
[TBL] [Abstract][Full Text] [Related]
42. Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis.
Mutoh T; Kiuchi K; Sobue I; Naoi M
Clin Chim Acta; 1984 Jul; 140(3):223-30. PubMed ID: 6432371
[TBL] [Abstract][Full Text] [Related]
43. Adult GM1 gangliosidosis: immunohistochemical and ultrastructural findings in an autopsy case.
Yoshida K; Ikeda S; Kawaguchi K; Yanagisawa N
Neurology; 1994 Dec; 44(12):2376-82. PubMed ID: 7991129
[TBL] [Abstract][Full Text] [Related]
44. The abnormalities of beta-galactosidase in GM1-gangliosidoses.
Kudoh T
Tohoku J Exp Med; 1978 May; 125(1):93-101. PubMed ID: 27879
[TBL] [Abstract][Full Text] [Related]
45. Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
Takamura A; Higaki K; Ninomiya H; Takai T; Matsuda J; Iida M; Ohno K; Suzuki Y; Nanba E
J Neurochem; 2011 Aug; 118(3):399-406. PubMed ID: 21574998
[TBL] [Abstract][Full Text] [Related]
46. Thymic alterations in feline GM1 gangliosidosis.
Cox NR; Ewald SJ; Morrison NE; Gentry AS; Schuler M; Baker HJ
Vet Immunol Immunopathol; 1998 Jun; 63(4):335-53. PubMed ID: 9656423
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain.
Broekman ML; Tierney LA; Benn C; Chawla P; Cha JH; Sena-Esteves M
Gene Ther; 2009 Feb; 16(2):303-8. PubMed ID: 18818671
[TBL] [Abstract][Full Text] [Related]
48. GM1 gangliosidosis: phenotypic variation in a single family.
Farrell DF; Ochs U
Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
[TBL] [Abstract][Full Text] [Related]
49. Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.
Samoylova TI; Martin DR; Morrison NE; Hwang M; Cochran AM; Samoylov AM; Baker HJ; Cox NR
Metab Brain Dis; 2008 Jun; 23(2):161-73. PubMed ID: 18421424
[TBL] [Abstract][Full Text] [Related]
50. A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis.
Hinderer C; Nosratbakhsh B; Katz N; Wilson JM
Hum Gene Ther; 2020 Nov; 31(21-22):1169-1177. PubMed ID: 33045869
[TBL] [Abstract][Full Text] [Related]
51. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
[TBL] [Abstract][Full Text] [Related]
52. Rapid detection of GM1 ganglioside in cerebrospinal fluid in dogs with GM1 gangliosidosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Satoh H; Yamauchi T; Yamasaki M; Maede Y; Yabuki A; Chang HS; Asanuma T; Yamato O
J Vet Diagn Invest; 2011 Nov; 23(6):1202-7. PubMed ID: 22362802
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B.
Przybilla MJ; Ou L; Tăbăran AF; Jiang X; Sidhu R; Kell PJ; Ory DS; O'Sullivan MG; Whitley CB
Mol Genet Metab; 2019 Feb; 126(2):139-150. PubMed ID: 30528226
[TBL] [Abstract][Full Text] [Related]
54. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
Kwak JE; Son MY; Son YS; Son MJ; Cho YS
Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
[TBL] [Abstract][Full Text] [Related]
55. GM1-ganglioside-induced Abeta assembly on synaptic membranes of cultured neurons.
Yamamoto N; Fukata Y; Fukata M; Yanagisawa K
Biochim Biophys Acta; 2007 May; 1768(5):1128-37. PubMed ID: 17306220
[TBL] [Abstract][Full Text] [Related]
56. High levels of GM1-ganglioside beta-galactosidase in the salivary glands and GM1-like-ganglioside storage in parotids of deficient mice.
Nowroozi N; Kim S; Gupta A; Warita H; Zernik J
J Craniofac Genet Dev Biol; 1999; 19(1):41-7. PubMed ID: 10378147
[TBL] [Abstract][Full Text] [Related]
57. Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery.
Broekman ML; Baek RC; Comer LA; Fernandez JL; Seyfried TN; Sena-Esteves M
Mol Ther; 2007 Jan; 15(1):30-7. PubMed ID: 17164772
[TBL] [Abstract][Full Text] [Related]
58. Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency.
Read DH; Harrington DD; Keenana TW; Hinsman EJ
Science; 1976 Oct; 194(4263):442-5. PubMed ID: 824730
[TBL] [Abstract][Full Text] [Related]
59. Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis.
Tsunogai T; Ohashi T; Shimada Y; Higuchi T; Kimura A; Watabe AM; Kato F; Ida H; Kobayashi H
Mol Ther Methods Clin Dev; 2022 Jun; 25():448-460. PubMed ID: 35615711
[TBL] [Abstract][Full Text] [Related]
60. Development of lysosomal storage in mice with targeted disruption of the beta-galactosidase gene: a model of human G(M1)-gangliosidosis.
Itoh M; Matsuda J; Suzuki O; Ogura A; Oshima A; Tai T; Suzuki Y; Takashima S
Brain Dev; 2001 Oct; 23(6):379-84. PubMed ID: 11578847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
